Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
196 hedge funds and large institutions have $1.79B invested in Cantel Medical Corporation in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 80 reducing their positions, and 38 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less capital invested
Capital invested by funds: $1.86B → $1.79B (-$69.8M)
7% less funds holding
Funds holding: 210 → 196 (-14)
20% less call options, than puts
Call options by funds: $5.14M | Put options by funds: $6.43M
29% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 80
34% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$60.5M |
| 2 |
LGP
Leonard Green & Partners
Los Angeles,
California
|
+$29.6M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$13.3M |
| 4 |
FAM
Fred Alger Management
New York
|
+$13.1M |
| 5 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$7.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$73.7M |
| 2 |
Goldman Sachs
New York
|
-$27M |
| 3 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$10.4M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$9.39M |
| 5 |
CI Investments Inc
Toronto,
Ontario, Canada
|
-$9.12M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MIM
226
Macroview Investment Management
Bethesda,
Maryland
| – | -$3K | -74 | Closed |
|
|
1IA
227
1834 Investment Advisors
Milwaukee,
Wisconsin
| – | -$3K | -58 | Closed |
|
228
Bessemer Group
Woodbridge,
New Jersey
| – | -$1K | -16 | Closed |
|
|
FBT
229
First Bank & Trust
Brookings,
South Dakota
| – | -$1K | -16 | Closed |
|
|
EI
230
Ellevest Inc
New York
| – | +$197 | +4 | New |
|
CMD Hedge Fund Activity: Q3 2020 in Review
196 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q3 2020, worth a combined $1.79B — down 3.7% from $1.86B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of CMD and 25 opened new positions — a net loss of 13 holders — while 80 trimmed existing stakes and 57 added.
The largest buyer was JP Morgan Chase, adding an estimated $60.5M. The largest seller was Wasatch Advisors, cutting an estimated $73.7M.
- 196 institutional investors held Cantel Medical Corporation (CMD) as of Q3 2020, down from 210 in Q2 2020.
- Funds reported $1.79B of Cantel Medical Corporation stock for Q3 2020, down 3.7% quarter-over-quarter.
- 25 funds opened new Cantel Medical Corporation positions in Q3 2020 and 38 closed out, a net change of -13 holders.
- The largest Cantel Medical Corporation buyer in Q3 2020 was JP Morgan Chase, an estimated $60.5M added.
- The largest Cantel Medical Corporation seller in Q3 2020 was Wasatch Advisors, an estimated $73.7M sold.
Based on aggregated 13F filings for Q3 2020.